Found: 5
Select item for more details and to access through your institution.
Phase 1 Clinical Trials: Challenges and Opportunities in Latin America.
- Published in:
- Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 3, p. 168, doi. 10.36401/JIPO-23-42
- By:
- Publication type:
- Article
Correlation between work productivity loss and EORTC QLQ-C30 and -BR23 domains from the MONALEESA-7 trial of premenopausal women with HR+/HER2− advanced breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221081203
- By:
- Publication type:
- Article
Health-related quality of life in premenopausal women with hormone-receptor-positive, HER2-negative advanced breast cancer treated with ribociclib plus endocrine therapy: results from a phase III randomized clinical trial (MONALEESA-7).
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920943065
- By:
- Publication type:
- Article
heredERA Breast Cancer: a phase III, randomized, open-label study evaluating the efficacy and safety of giredestrant plus the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with previously untreated HER2-positive, estrogen receptor-positive locally advanced or metastatic breast cancer
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12179-9
- By:
- Publication type:
- Article
A phase 2 study of first‐line nivolumab in patients with locally advanced or metastatic cutaneous squamous‐cell carcinoma.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 24, p. 4223, doi. 10.1002/cncr.34463
- By:
- Publication type:
- Article